Background Prospective data on the risk of recurrence among women with hormone
receptor–positive early breast cancer who temporarily discontinue endocrine therapy to attempt …

Background Adjuvant abemaciclib plus endocrine therapy previously showed a significant
improvement in invasive disease-free survival and distant relapse-free survival in hormone …

Background Antibody–drug conjugates have emerged as a powerful strategy in cancer therapy
and combine the ability of monoclonal antibodies to specifically target tumour cells with …

The purpose of the present study was to identify histological surrogate predictive markers of
pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) in triple-…

MicroRNA (miRNA), which are stably present in serum, have been reported to be potentially
useful for detecting cancer. In the present study, we examined the expression profiles of …

The purpose of this study was to determine the safety, distribution, internal dosimetry, and
initial human epidermal growth factor receptor 2 (HER2)–positive tumor images of 64 Cu-…

This study investigated whether the consumption of a diet in which high-β-glucan barley
replaced rice would reduce the visceral fat area as well as the serum low-density lipoprotein …

Drug resistance is a major obstacle to the successful chemotherapy. Several ATP-binding
cassette (ABC) transporters including ABCB1, ABCC1 and ABCG2 have been known to be …

Background The long-term outcomes and risk factors of paclitaxel-induced peripheral
neuropathy (PIPN) have not yet been fully elucidated. Methods We identified 219 breast cancer …

Background The presence of tumour-infiltrating lymphocytes (TILs) is a favourable prognostic
factor in patients with early breast cancer. Programmed cell death-1 (PD-1) and its ligand …